|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 1400 Crystal Drive |
Address2 | Suite 300 |
| City | Arlington |
State | VA |
Zip Code | 22202 |
Country | USA |
3. Principal place of business (if different than line 2)
| City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 46803-12
|
||||||||
|
6. House ID# 343580000
|
||||||||
| TYPE OF REPORT | 8. Year | 2020 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Dorothy Farrell |
Date | 7/15/2020 1:05:26 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Coalition for Health Funding call with Chris Bigelow, House Appropriations Committee Deputy Staff Director.
Letter to House and Senate Military Construction, VA, and Related Agencies Appropriations Subcommittee leaders urging inclusion of at least $50 million for VA research in future COVID-19 supplemental funding bills. The letter was submitted on May 21 by the Friends of the VA, with AACP as a signatory.
Signed a letter sent to Senate and House leadership (Senators Mitch McConnell and Chuck Schumer, and House leaders Nancy Pelosi and Kevin McCarthy), led by the Friends of NIDDK, requesting emergency funds for NIDDK be included in next COVID-19 relief bill, to investigate COVID-19 and comorbidities associated with diseases and research areas in NIDDK's portfolio.
AACP endorsed the Research Investment to Secure the Economy (RISE) Act, a bipartisan piece of legislation which authorizes appropriations to science agencies of $26 billion to offset the costs of lost productivity to research labs during the pandemic.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jasey |
Cardenas |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
Signed onto letter led by National Association of County and City Health Officials (NACCHO) sent to Senators Smith and Booker thanking them for introducing the bill, which is a companion to the House version included in the Heroes Act. Senators Tina Smith (D-MN) and Cory Booker (D-NJ) introduced the Senate version of the Public Health Workforce Loan Repayment Act. The bill would provide loan repayment for professionals who serve two years in a local, state or tribal health department.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jasey |
Cardenas |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Joined TFAH, APHA, ASTHO, Big Cities Health Coalition, and NACCHO in a sign on letter to HHS Secretary Azar urging him to strengthen and affirm the role of CDC.
Joined the American Society for Microbiology, American Public Health Association, Association of Public Health Laboratories, National Association of County and City Health Officials and Trust for Americaas Health, on a letter urging HHS Secretary Azar to extend the COVID-19 public health emergency. The letter asks HHS to renew the current public health emergency (PHE) declaration for at least an additional 90 days before it expires on July 25. It is imperative that the federal government continue to deploy all resources and authorities necessary to protect the public, spur the development of medical countermeasures, and assist states and localities as they continue to respond to this urgent situation.
Pharmacy HIT Collaborative comments to DEA 2181: Reopened Electronic Prescriptions for Controlled Substances; Interim Final Rule.
17. House(s) of Congress and Federal agencies Check if None
Health & Human Services - Dept of (HHS), Drug Enforcement Administration (DEA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jasey |
Cardenas |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code IMM
16. Specific lobbying issues
Signed onto DACA Health Professions Letter sent to Congressional leadership urging them to maintain work authorization for individuals currently in Deferred Action for Childhood Arrivals (DACA) status during the COVID-19 national emergency.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jasey |
Cardenas |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code IND
16. Specific lobbying issues
Joined TFAH, APHA, ASTHO, BPC Action, NACCHO, and PHAB in an organizational sign-on letter to congressional leadership in support of increased, sustained annual funding for state/local/tribal/territorial public health infrastructure.
Signed onto letter to the Senate (McConnell, Schumer, Murkowski, Udall) led by AI/AN Partners to ask for funding for tribes and IHS to effectively respond to COVID-19, including at least a match of funding level in H.R. 6800, the HEROES Act, for the Bureau of Indian Affairs and Indian Health Service. The letter also urged inclusion of S. 2871, the Indian Health Service Health Professions Tax Fairness Act, in the next coronavirus response bill.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jasey |
Cardenas |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
| Lobbyist Name | Description of Offense(s) |